These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 5128833

  • 21. [Ineffectiveness of diltiazem in Duchenne muscular dystrophy: a placebo-controlled double-blind study].
    Toifl K, Presterl E, Graninger W.
    Wien Klin Wochenschr; 1991; 103(8):232-5. PubMed ID: 1907056
    [Abstract] [Full Text] [Related]

  • 22. [Progressive muscle dystrophy. II. Enzyme activity chages in serum in progressive muscle dystrophy].
    Lujf A, Sluga E, Moser K.
    Wien Klin Wochenschr; 1971 Feb 19; 83(7):109-13. PubMed ID: 5547427
    [No Abstract] [Full Text] [Related]

  • 23. [Diagnosis of female carriers of Duchenne's progressive muscular dystrophy using discriminative analysis of various serum enzyme activities].
    Büsing CM, Heyck H, Laudahn G.
    Klin Wochenschr; 1969 Oct 15; 47(20):1099-103. PubMed ID: 5381991
    [No Abstract] [Full Text] [Related]

  • 24. [Lipid peroxidation in children with Duchenne's hereditary myopathy].
    Grinio LP, Orlov ON, Prilipko LL, Kagan VE.
    Biull Eksp Biol Med; 1984 Oct 15; 98(10):423-5. PubMed ID: 6498321
    [Abstract] [Full Text] [Related]

  • 25. [Study on progressive muscular dystrophy. 1. Influence of the various drugs on serum enzyme activity and the degree of disability].
    Kanno M, Annaka S, Sato N, Shinoda M.
    Iryo; 1968 Dec 15; 22(12):1364-71. PubMed ID: 5717702
    [No Abstract] [Full Text] [Related]

  • 26. [Clinico-statistical considerations on a group of 22 patients with progressive muscular dystrophy].
    Garofalo E, Marcer V.
    Fracastoro; 1966 Dec 15; 59(6):621-38. PubMed ID: 5998705
    [No Abstract] [Full Text] [Related]

  • 27. [Myocardial lesions in several forms of progressive muscular atrophy].
    Popov'ian MD, Dubinskaia EE, Proshina OV, Tul'skaia MP, Loginova LA.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984 Dec 15; 84(3):330-5. PubMed ID: 6720172
    [Abstract] [Full Text] [Related]

  • 28. [The spectrum of lactate dehydrogenase isoenzymes in children with the pseudohypertrophic form of progressive muscular dystrophy and in their relatives].
    Droznina TA, Markelov IM.
    Vopr Psikhiatr Nevropatol; 1968 Dec 15; 13():126-33. PubMed ID: 5740998
    [No Abstract] [Full Text] [Related]

  • 29. Serum myoglobin in muscular dystrophy.
    Kagen LJ, Moussavi S, Miller SL, Tsairis P.
    Muscle Nerve; 1980 Dec 15; 3(3):221-6. PubMed ID: 7374673
    [Abstract] [Full Text] [Related]

  • 30. Duchenne muscular dystrophy carrier detection using logistic discrimination: serum creatine kinase, hemopexin, pyruvate kinase, and lactate dehydrogenase in combination.
    Percy ME, Andrews DF, Thompson MW.
    Am J Med Genet; 1982 Sep 15; 13(1):27-38. PubMed ID: 7137219
    [Abstract] [Full Text] [Related]

  • 31. [Effect of drug administration on the child with progressive muscular dystrophy].
    Nakahara T, Annaka S, Baba T, Kanno M.
    Iryo; 1969 Oct 15; 23(10):1319-27. PubMed ID: 5364983
    [No Abstract] [Full Text] [Related]

  • 32. [Systematic neonatal detection of Duchenne's muscular dystrophy. Results after 10 years' of experience in Lyons (France)].
    Plauchu H, Cordier MP, Carrier HN, Dellamonica C, Dorche C, Guibaud P, Lauras B, Cotte J, Robert JM.
    J Genet Hum; 1987 Aug 15; 35(4):217-30. PubMed ID: 3655748
    [Abstract] [Full Text] [Related]

  • 33. Serum enzymes in disease of skeletal muscle.
    Rosalki SB.
    Clin Lab Med; 1989 Dec 15; 9(4):767-81. PubMed ID: 2686911
    [Abstract] [Full Text] [Related]

  • 34. Studies on enzymatic activity in serum obtained from muscular dystrophic patients.
    Yamaji K, Imai H, Esaki K, Tokoro T, Hotta K.
    Nagoya Med J; 1968 Apr 15; 14(1):55-64. PubMed ID: 5696330
    [No Abstract] [Full Text] [Related]

  • 35. Anaesthesia and serum creatine phosphokinase levels in patients with Duchenne's pseudohypertrophic muscular dystrophy.
    Richards WC.
    Anaesth Intensive Care; 1972 Nov 15; 1(2):150-3. PubMed ID: 4668562
    [No Abstract] [Full Text] [Related]

  • 36. [Clinico-biochemical and genetic studies of myopathy].
    Davidenkova EF, Droznina TA, Markelov IM.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1966 Nov 15; 66(11):1623-8. PubMed ID: 6001049
    [No Abstract] [Full Text] [Related]

  • 37. Metabolic effects of human growth hormone and of estrogens in boys with Duchenne muscular dystrophy.
    Rudman D, Chyatte SB, Patterson JH, Gerron GG, O'Beirne I, Barlow J, Jordan A, Shavin JS.
    J Clin Invest; 1972 May 15; 51(5):1118-24. PubMed ID: 5057128
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Steroid treatment of Duchenne's muscular dystrophy].
    Luz Aviles C, Gutiérrez C, Novoa F, Gil E, Stuardo A.
    Rev Chil Pediatr; 1982 May 15; 53(3):187-91. PubMed ID: 6760264
    [No Abstract] [Full Text] [Related]

  • 40. [Double-blind study of the efficacy of an antiserotoninergic drug, pizotifen, in Duchenne's muscular dystrophy].
    Steru D, Paclet JP, Barthelet G, Gailliard G, Piton A, Monchartre E, Roche R, Galli J, Lancrenon S, Fermanian J.
    Arch Fr Pediatr; 1987 May 15; 44(6):461-5. PubMed ID: 3619586
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.